60 DEGREES PHARMACEUTICALS, INC. Research and Development Expense
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- 60 DEGREES PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-06-30 was $598.65K, a 158.14% increase year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-03-31 was $281.46K, a 24.10% decline year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-12-31 was $638.87K, a 4.06% increase year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-09-30 was $809.78K, a 13.86% decline year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. research and development expense for fiscal 2025 was $2.11M, a 57.76% decline from fiscal 2024.
- 60 DEGREES PHARMACEUTICALS, INC. research and development expense for fiscal 2024 was $4.99M, a 620.84% increase from fiscal 2023.
- 60 DEGREES PHARMACEUTICALS, INC. research and development expense for fiscal 2023 was $691.77K, a 31.62% increase from fiscal 2022.
- 60 DEGREES PHARMACEUTICALS, INC. research and development expense for fiscal 2022 was $525.56K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $598.65K 10-Q · filed 2026-08-14 | $880.12K 10-Q · filed 2026-08-14 | $1.52M derived: sum of 3 quarters · filed 2026-08-14 | $2.33M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $281.46K 10-Q · filed 2026-05-15 | $920.34K derived: sum of 2 quarters · filed 2026-05-15 | $1.73M derived: sum of 3 quarters · filed 2026-05-15 | $1.96M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $638.87K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.45M derived: sum of 2 quarters · filed 2026-03-30 | $1.68M derived: sum of 3 quarters · filed 2026-08-14 | $2.11M 10-K · filed 2026-03-30 | ||
| 2025-09-30 | $809.78K 10-Q · filed 2025-11-13 | $1.04M derived: sum of 2 quarters · filed 2026-08-14 | $1.47M 10-Q · filed 2025-11-13 | $2.03M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $231.91K 10-Q · filed 2026-08-14 | $249.88K 10-Q · filed 2025-08-13 | $602.73K 10-Q · filed 2026-08-14 | $657.51K 10-Q · filed 2025-08-13 | $1.22M derived: sum of 3 quarters · filed 2026-08-14 | $2.16M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $370.81K 10-Q · filed 2026-05-15 | $407.62K 10-Q · filed 2025-05-15 | $984.77K derived: sum of 2 quarters · filed 2026-05-15 | $1.92M derived: sum of 3 quarters · filed 2026-05-15 | $5.02M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $613.96K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.55M derived: sum of 2 quarters · filed 2026-03-30 | $4.65M derived: sum of 3 quarters · filed 2026-03-30 | $4.99M 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $940.06K 10-Q · filed 2025-11-13 | $4.04M derived: sum of 2 quarters · filed 2025-11-13 | $4.37M 10-Q · filed 2025-11-13 | $4.47M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $3.10M 10-Q · filed 2025-08-13 | $3.43M 10-Q · filed 2025-08-13 | $3.53M derived: sum of 3 quarters · filed 2025-08-13 | $3.80M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $337.18K 10-Q · filed 2025-05-15 | $437.38K derived: sum of 2 quarters · filed 2025-05-15 | $701.09K derived: sum of 3 quarters · filed 2025-05-15 | $904.96K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $100.20K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $363.90K derived: sum of 2 quarters · filed 2025-03-27 | $567.78K derived: sum of 3 quarters · filed 2025-03-27 | $691.77K 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $263.70K 10-Q · filed 2024-11-14 | $467.57K derived: sum of 2 quarters · filed 2024-11-14 | $591.57K 10-Q · filed 2024-11-14 | $795.03K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $203.87K 10-Q · filed 2024-08-14 | $327.87K 10-Q · filed 2024-08-14 | $531.32K derived: sum of 3 quarters · filed 2024-08-14 | $558.98K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $123.99K 10-Q · filed 2024-05-15 | $327.45K derived: sum of 2 quarters · filed 2024-05-15 | $355.11K derived: sum of 3 quarters · filed 2024-05-15 | $586.50K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $203.46K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $231.11K derived: sum of 2 quarters · filed 2024-04-01 | $462.51K derived: sum of 3 quarters · filed 2024-04-01 | $525.56K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $27.66K 10-Q · filed 2023-11-20 | $259.05K derived: sum of 2 quarters · filed 2023-11-20 | $322.11K 10-Q · filed 2023-11-20 | |||
| 2022-06-30 | $231.39K 10-Q · filed 2023-08-25 | $294.45K 10-Q · filed 2023-08-25 |